🇺🇸 FDA
Patent

US 9593136

Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase

granted A61KA61K31/135A61K31/66

Quick answer

US patent 9593136 (Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/135, A61K31/66